TRACON Pharmaceuticals Price Prediction

TCONDelisted Stock  USD 1.60  0.55  52.38%   
As of today, the relative strength index (RSI) of TRACON Pharmaceuticals' share price is approaching 36. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling TRACON Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

36

 
Oversold
 
Overbought
The successful prediction of TRACON Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with TRACON Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Using TRACON Pharmaceuticals hype-based prediction, you can estimate the value of TRACON Pharmaceuticals from the perspective of TRACON Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in TRACON Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying TRACON because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

TRACON Pharmaceuticals after-hype prediction price

    
  USD 1.6  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Intrinsic
Valuation
LowRealHigh
1.521.521.76
Details
Naive
Forecast
LowNextHigh
1.501.501.50
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.371.511.66
Details

TRACON Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of TRACON Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in TRACON Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of TRACON Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

TRACON Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting TRACON Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on TRACON Pharmaceuticals' historical news coverage. TRACON Pharmaceuticals' after-hype downside and upside margins for the prediction period are 1.60 and 1.60, respectively. We have considered TRACON Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.60
1.60
After-hype Price
1.60
Upside
TRACON Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of TRACON Pharmaceuticals is based on 3 months time horizon.

TRACON Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as TRACON Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TRACON Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with TRACON Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
8 Events / Month
15 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.60
1.60
0.00 
0.00  
Notes

TRACON Pharmaceuticals Hype Timeline

TRACON Pharmaceuticals is at this time traded for 1.60. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. TRACON is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on TRACON Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 1.60. The company recorded earning per share (EPS) of 106.4. TRACON Pharmaceuticals last dividend was issued on the 8th of November 2019. The entity had 1:20 split on the 10th of April 2024. Given the investment horizon of 90 days the next estimated press release will be in about 8 days.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

TRACON Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to TRACON Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict TRACON Pharmaceuticals' future price movements. Getting to know how TRACON Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how TRACON Pharmaceuticals may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
RZLTRezolute 0.18 8 per month 3.11  0.04  6.81 (5.54) 30.01 
XOMAXOMA Corp(0.28)8 per month 3.11 (0) 4.36 (5.56) 12.62 
SIOXSio Gene Therapies 0.00 5 per month 0.00 (0.12) 2.33 (2.38) 11.21 
VINCVincerx Pharma(0.23)4 per month 0.00 (0.22) 6.06 (7.32) 48.57 
HSTOHistogen 0.00 0 per month 0.00 (0.12) 4.76 (4.55) 131.40 
ENTXEntera Bio(0.03)4 per month 0.00 (0.04) 5.47 (5.47) 29.16 
TPSTTempest Therapeutics(0.47)4 per month 0.00 (0.14) 6.38 (8.53) 29.55 
BTTXBetter Therapeutics 0.00 0 per month 0.00 (0.14) 12.64 (9.62) 36.53 
ANTXAN2 Therapeutics 0.01 9 per month 1.86  0.06  3.64 (3.42) 28.03 
MIROMiromatrix Medical(0.06)2 per month 5.26  0.05  11.73 (8.87) 38.49 
IKTInhibikase Therapeutics 0.01 8 per month 4.82  0.13  13.45 (9.09) 37.40 
PMVPPmv Pharmaceuticals(0.1)3 per month 2.12 (0.03) 3.75 (3.77) 13.98 
ANEBAnebulo Pharmaceuticals 0.03 5 per month 0.00 (0.02) 8.85 (11.48) 76.00 
CADLCandel Therapeutics(0.33)10 per month 3.78 (0.02) 6.70 (5.78) 22.01 
ACXPAcurx Pharmaceuticals LLC(0.05)8 per month 0.00 (0.26) 3.55 (6.47) 28.75 
MNPRMonopar Therapeutics(2.62)9 per month 7.90  0.13  15.93 (9.50) 653.56 
KRONKronos Bio(0.05)10 per month 0.00 (0.06) 5.56 (6.25) 16.20 
CYCNCyclerion Therapeutics(0.17)1 per month 0.00 (0.05) 16.40 (15.79) 77.82 
LRMRLarimar Therapeutics(0.49)9 per month 0.00 (0.06) 10.87 (9.55) 26.71 
ADXNAddex Therapeutics(0.1)4 per month 5.08  0.01  9.74 (7.40) 69.82 
ACHLAchilles Therapeutics PLC(0.03)4 per month 1.53  0.11  3.06 (2.88) 38.16 

TRACON Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine TRACON price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TRACON using various technical indicators. When you analyze TRACON charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About TRACON Pharmaceuticals Predictive Indicators

The successful prediction of TRACON Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as TRACON Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of TRACON Pharmaceuticals based on analysis of TRACON Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to TRACON Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to TRACON Pharmaceuticals's related companies.

Story Coverage note for TRACON Pharmaceuticals

The number of cover stories for TRACON Pharmaceuticals depends on current market conditions and TRACON Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that TRACON Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about TRACON Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

TRACON Pharmaceuticals Short Properties

TRACON Pharmaceuticals' future price predictability will typically decrease when TRACON Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of TRACON Pharmaceuticals often depends not only on the future outlook of the potential TRACON Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TRACON Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding32.7 M
Cash And Short Term Investments8.6 M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in TRACON Stock

If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance